The list now includes morphine sulfate, a drug used to treat severe pain, and epinephrine, a drug used to treat allergic reactions.
The new policies say the FDA doesn’t intend to take action against pharmacies for compounding products that are essentially copies of commercially available drugs or for supplying hospitals with drugs without receiving patient-specific prescriptions, as long as specific guidelines outlined in the policy are met.
More articles on pharmacy:
HHS unveils plan to distribute Gilead’s COVID-19 drug
Two-thirds of hospital pharmacies have reduced staff during COVID-19 pandemic, ASHP survey finds
New CMS rule could raise out-of-pocket drug costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
